ARTICLE SUMMARY:
CMS posted its first “NCD Wait List” of pending Medicare coverage determinations, and two proposed coverage decisions all in the same day. Meanwhile, pandemic burdens are starting to show up in FDA’s broader device review performance, and European policymakers took another baby step toward the much anticipated EU-wide device database. That and more in this week’s Pathways’ Picks.
Abbott Laboratories Inc.’s CardioMEMS remote heart failure monitor appears to be headed for a formal Medicare coverage analysis, according to a first-time CMS “dashboard” of potentially pending National Coverage Determinations on October 16. That news leads off this week’s round of Pathways’ Picks.
